Literature DB >> 3525416

Composition of affinity-purified alpha-hemolysin of Escherichia coli.

G A Bohach, I S Snyder.   

Abstract

Escherichia coli alpha-hemolysin was purified from culture supernatants by affinity chromatography, using a hemolysis-neutralizing monoclonal antibody ligand. Purified hemolysin contains several proteins and lipopolysaccharides. Thus, alpha-hemolysin exists as a macromolecular complex and may be exported from E. coli cells by outer membrane fragmentation.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3525416      PMCID： PMC260895          DOI： 10.1128/iai.53.2.435-437.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  Transport of hemolysin across the outer membrane of Escherichia coli requires two functions.

Authors:  W Wagner; M Vogel; W Goebel
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

2.  Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli.

Authors:  W Goebel; J Hedgpeth
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

3.  Partial characterisation of Escherichia coli haemolysin.

Authors:  R P Rennie; J P Arbuthnott
Journal:  J Med Microbiol       Date:  1974-05       Impact factor: 2.472

4.  Studies on the origin of the alpha-haemolysin produced by Escherichia coli.

Authors:  S E Jorgensen; E C Short; H J kurtz; H K Mussen; G K Wu
Journal:  J Med Microbiol       Date:  1976-05       Impact factor: 2.472

5.  Chemical and immunological analysis of the complex structure of Escherichia coli alpha-hemolysin.

Authors:  G A Bohach; I S Snyder
Journal:  J Bacteriol       Date:  1985-12       Impact factor: 3.490

6.  Production and characteristics of hemolysins of Escherichia coli.

Authors:  I S Snyder; N A Koch
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

7.  Isolation of a lipopolysaccharide mutant of Neisseria gonorrhoeae: an analysis of the antigenic and biologic difference.

Authors:  S A Morse; M A Apicella
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

8.  Cytotoxic activity of partially purified Escherichia coli alpha haemolysin.

Authors:  S J Cavalieri; I S Snyder
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

9.  Molecular cloning and physical characterization of a chromosomal hemolysin from Escherichia coli.

Authors:  R A Welch; R Hull; S Falkow
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  The structure of cloned hemolysin DNA from plasmid pHly185.

Authors:  J M Stark; C W Shuster
Journal:  Plasmid       Date:  1983-07       Impact factor: 3.466
View more
  11 in total

1.  Characterization of monoclonal antibodies against the Escherichia coli hemolysin.

Authors:  S Pellett; D F Boehm; I S Snyder; G Rowe; R A Welch
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Partial purification of alpha-hemolysin in Escherichia coli.

Authors:  F Nistiar; V Janigová; J Durovicová; H Puzová
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

3.  Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysin.

Authors:  M E Bauer; R A Welch
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Glycerophospholipid:cholesterol acyltransferase complexed with lipopolysaccharide (LPS) is a major lethal exotoxin and cytolysin of Aeromonas salmonicida: LPS stabilizes and enhances toxicity of the enzyme.

Authors:  K K Lee; A E Ellis
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

5.  Influence of growth temperature and lipopolysaccharide on hemolytic activity of Serratia marcescens.

Authors:  K Poole; V Braun
Journal:  J Bacteriol       Date:  1988-11       Impact factor: 3.490

6.  Characterization of hemolysin of Moraxella bovis using a hemolysis-neutralizing monoclonal antibody.

Authors:  F M Billson; C Harbour; W P Michalski; J M Tennent; J R Egerton; J L Hodgson
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50.

Authors:  M A Curtis; A Thickett; J M Slaney; M Rangarajan; J Aduse-Opoku; P Shepherd; N Paramonov; E F Hounsell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

8.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Purification and characterization of a protease from Actinobacillus pleuropneumoniae serotype 1, an antigen common to all the serotypes.

Authors:  E Negrete-Abascal; V R Tenorio; A L Guerrero; R M García; M E Reyes; M de la Garza
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

10.  Analysis of toxinogenic functions associated with the RTX repeat region and monoclonal antibody D12 epitope of Escherichia coli hemolysin.

Authors:  G E Rowe; S Pellett; R A Welch
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.